# Can LL-37 enhance tissue regeneration in aging individuals?

Canonical source: https://retacompare.com/research/can-ll-37-enhance-tissue-regeneration-in-aging-individuals

Peptide Longevity Q&A · 2026-03-10


    Research indicates that LL-37, when incorporated into a multifunctional nanocomposite, enhances tissue repair by promoting endothelial cell migration and angiogenesis. This suggests potential benefits for tissue regeneration, particularly in inflammatory conditions associated with aging.

What the research shows

The study focused on developing a bimetallic ion-modified metal-organic framework (MOF) nanozyme composite, named MOF-FeAg-AMP@HA, to address periapical periodontitis (AP). The researchers engineered this composite to possess pH-responsive dual enzymatic activities, which allowed it to generate bactericidal hydroxyl radicals under acidic conditions and scavenge reactive oxygen species (ROS) under neutral conditions. The incorporation of LL-37 into the composite was aimed at enhancing its antibacterial properties by disrupting bacterial membranes. In vitro tests demonstrated that the nanocomposite effectively eradicated bacterial biofilms and promoted tissue repair by stimulating endothelial cell migration and angiogenesis. In vivo experiments using a rat AP model showed that the nanocomposite reduced alveolar bone resorption and induced macrophage polarization toward an anti-inflammatory phenotype, which is beneficial for bone regeneration.

Why it matters for longevity

The findings from this research highlight the potential role of LL-37 in enhancing tissue regeneration, a critical aspect of maintaining healthspan and combating age-related degeneration. As individuals age, the body's ability to repair tissues diminishes, often leading to chronic inflammatory conditions and impaired healing. By promoting processes such as angiogenesis and endothelial cell migration, LL-37 may contribute to improved tissue health and regeneration, which are essential for longevity. Furthermore, the ability of the engineered nanocomposite to modulate the inflammatory microenvironment suggests that it could play a role in reducing chronic inflammation, a known contributor to many age-related diseases.

Key findings at a glance

LL-37 enhances antibacterial activity by disrupting bacterial membranes.

The MOF-FeAg-AMP@HA composite exhibits pH-responsive enzymatic activities.

In vitro, the composite effectively eradicates bacterial biofilms.

It promotes endothelial cell migration and angiogenesis, aiding tissue repair.

In vivo, it reduces alveolar bone resorption and modulates macrophage polarization.

Research indicates potential for precision therapy in inflammatory conditions.

How LL-37 works (background)

LL-37 is an antimicrobial peptide that plays a significant role in the immune response. It is known for its ability to disrupt bacterial membranes, leading to bacterial cell death. In the context of tissue regeneration, LL-37 has been shown to stimulate various cellular processes, including angiogenesis and cell migration, which are essential for effective healing. The incorporation of LL-37 into the MOF-FeAg-AMP@HA composite enhances its therapeutic potential by combining its antimicrobial properties with the composite's enzymatic activities, thereby addressing both infection control and tissue repair simultaneously.

Safety, caveats, and what we don't yet know

While the study presents promising results regarding the use of LL-37 in tissue regeneration and infection control, it is important to note that these findings are based on preclinical models. The safety and efficacy of LL-37 in human populations remain to be fully established. Further research is needed to explore potential side effects, optimal dosing, and long-term outcomes associated with the use of LL-37 in therapeutic applications. Additionally, the specific mechanisms by which LL-37 enhances tissue regeneration require further elucidation to better understand its role in aging and healthspan.

Bottom line

Incorporating LL-37 into a nanocomposite shows promise for enhancing tissue regeneration, particularly in inflammatory conditions. This suggests potential applications for improving healthspan and combating age-related degeneration.

Related questions

How does LL-37 affect inflammation in aging tissues?

LL-37 has been shown to modulate inflammatory responses, potentially reducing chronic inflammation in aging tissues. By promoting an anti-inflammatory environment, it may aid in tissue repair and regeneration.

What role does LL-37 play in wound healing?

LL-37 contributes to wound healing by enhancing antimicrobial activity and promoting cell migration and angiogenesis, essential processes for effective tissue repair.

Can LL-37 be used in combination with other therapies for longevity?

Research suggests that LL-37 may be combined with other therapeutic approaches to enhance tissue regeneration and combat age-related diseases, although further studies are needed to confirm these benefits.

Source: PubMed · ACS Nano · published 2026-03-10.

## Sources

- PubMed · ACS Nano: https://pubmed.ncbi.nlm.nih.gov/41733099/